Achiko AG appoints strategic and corporate development executive David Hodge to the position of Head of Corporate Development and announces the retirement of Christophe Laurent as Board Director. Mr. Hodge brings over 30 years' experience as a C-suite executive including Australia's then larger private equity firm (SBC Capital Partners), global investment banking (UBS), global manufacturing (Amcor) and industrial services businesses (Worley), and technology software businesses, with a focus on shareholder value creation. His broad sector experience includes healthcare, manufacturing, technology, and banking and finance.

He has been a strategic and corporate development advisor to world leading companies on business transformation and strategic challenges in emerging and developed markets, with a focus on profitable strategic growth. Clients have included ADM, Allnex, Amcor, AMVIG, Bayer, BTG, Campbells, Cornelius, Countrywide, Graphic Packaging International, MedHealth, NCO, Neovia, Nexans, Nine, SATS, SGH, Smith Group, Sumitomo, TGI Fridays, West Pharmaceutical, and Worley. Mr. Hodge is responsible for the development of Achiko's corporate presence especially in Switzerland, including for all matters regarding the development of the Board, corporate finance, and investor relations in its transformation to a world class diagnostics company.

Mr. Hodge started his role as Head of Corporate Development on 21 January 2022. Previously, Mr. Hodge led major capital raisings in Australia, Hong Kong, China, South East Asia, USA and Europe. He has led global strategic projects on every major continent and implemented numerous M&A projects worldwide.

Mr. Hodge has served as a Director and Chairman of public listed and private companies in Asia Pacific. As previously announced, Board Director Christophe Laurent will retire on 31 January 2022. The company will appoint a replacement for Mr. Laurent on or before the Annual General Meeting.